Abstract
The cytomegalovirus UL97 kinase inhibitor maribavir suppressed viral growth more effectively in lung fibroblasts than in skin fibroblasts, and some cellular kinase inhibitors enhanced its antiviral activity. These effects influence the phenotypic assay of drug susceptibility and suggest the possibility of therapeutically useful combinations of maribavir and cellular kinase inhibitors.
Original language | English (US) |
---|---|
Pages (from-to) | 2557-2559 |
Number of pages | 3 |
Journal | Antimicrobial agents and chemotherapy |
Volume | 50 |
Issue number | 7 |
DOIs | |
State | Published - Jul 2006 |
Externally published | Yes |
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases